| | Key Words | | Study Title
| | Status
|
| | Post Infective, Diarrhea Predominant, Irritable Bowel Syndrome | | Trial of Oral Delayed-Release Mesalamine in Post-Infective Irritable Bowel Syndrome | | Open to Enrollment |
| | Asthma, Gastroesophageal Reflux, Pulmonary Inflammation | | Elucidation of Acid-Induced Pulmonary Inflammation | | Open to Enrollment |
| | GERD, Asthma, Exercize | | Effect of Acid Reflux on Respiratory Physiology During Exercize in Athletes with GER - Response to Acid Suppression | | Open to Enrollment |
| | Opioid-Induced Constipation | | Evaluation of Tegaserod for the Treatment of Opioid-Induced Constipation (OIC) in Patients with Chronic Non-Cancer Pain | | Open to Enrollment |
| | Crohn's Disease, Certolizumab Pegol, TNF alpha | | Trial to Examine the Corticosteroid-Sparing Effect of Certolizumab Pegol in Patients with Moderate to Severe Crohn's Disease (COSPAR I) | | Open to Enrollment |
| | Eosinophilic Esophagitis, Eosinophils, dysphagia, GERD, allergic asthma | | A Pilot Study of the Treatment of Eosinophilic Esophagitis with Omalizumab | | Open to Enrollment |
| | Esophageal Carcinoma, Dysphagia, Polyflex Stent, Metal Stent | | Polyflex Esophageal Stents for Managaement of Locally Advanced Esophageal Cancer | | Open to Enrollment |
| | Secretin, ERCP, MRCP, Pancreatitis | | RG1068-16: A Phase III Study to Demonstrate the Efficacy and Safety of RG1068 (Synthetic Human Secretin) - Enhanced Magnetic Resonance Cholangiopancreatography (MRCP) in the Evaluation of Patients with a History of Acute or Acute Recurrent Pancreatitis | | Open to Enrollment |
| | Barrett's Esophagus, Ablation | | HALO Patient Registry | | Open to Enrollment |
| | Inflammatory Bowel Disease (IBD), Crohn's Disease, Ulcerative Colitis | | Cytokines in Inflammatory Bowel Disease (IBD) | | Open to Enrollment |
| | Adenomatous Polyps, Familial Adenomatous Polyposis (FAP), Celecoxib | | Phase III Placebo-Controlled Trial of Celecoxib in Genotype Positive Subjects with Familial Adenomatous Polyposis | | Open to Enrollment |
| | EoE, Salivary Proteins | | Salivary Analysis of Eosinophilic Esophagitis | | Open to Enrollment |
| | Celiac Plexus Block (CPN), Celiac Plexux Neurolysis, Chronic Opiod Use | | Comparison of Direct Intraneronal Injection of the Celiac Ganglia Versus Injection into the Perineronal Space for the Treatment of Chronic Abdominal Pain in Patients with Pancreatic Cancer or Chronic Pancreatitis | | Open to Enrollment |
| | Eosinophilic Esophagitis, Eosino[phils, Dysphagia, GERD | | Fluticasone versus Proton Pump Inhibitor (PPI) for Eosinophilic Esophagitis | | Closed |
| | Manometry Catheters, Schleroderma, Achalasia, Nutcracker Esophagus, Diffuse Esophageal Spasm, Hypertensive LES, Incontinence | | Comparison of Solid-State Catheters with Air Filled Multi-Balloon Catheters | | Closed |
| | Esophageal Cancer, Dysphagia | | Study of OncoGel Treatment as an Adjunctive Therapy to SRT in Patients with Inoperable Esophageal Cancer | | Closed |
| | Irritable Bowel Syndrome, Diarrhea-Predominant Irritable Bowel Syndrome | | Efficacy and Safety of 3 Different Doses of Rifaximin Administered BID for 2 or 4 Weeks in the Treatment of Patients with Diarrhea-Associated Irritable Bowel Syndrome | | Closed |
| | Hepatitis C, Peg-Intron, Ribavirin, KATT | | Treatment of Chronic Hepatitis C PEG-Intron and Ribavirin With or Without Adjuvant Therapy (KATT) | | Closed |
Physicians
